Investors Vote Against CICC's Mega Merger? A Closer Look at the 113.8 Billion Yuan Three-Way Deal

Deep News
08/29

In late August 2026, a landmark "three-in-one" merger in China's securities industry cleared a critical regulatory hurdle. CICC's proposal to absorb Dongxing Securities and Xinda Securities through a share swap received approval from the Shanghai Stock Exchange's merger committee, marking the first deal of its kind.

The approval came roughly 280 days after the three brokers first announced a trading halt. Post-merger, the new entity is projected to boast total assets exceeding one trillion yuan, with its branch network expanding from 247 to 441 outlets, propelling it from the fourteenth to the third position in industry rankings. Based on 2025 figures, revenue is expected to climb from 28.5 billion yuan to 37.2 billion yuan, securing a top-three spot. Parent company net capital would surge from 48.1 billion yuan to 103.3 billion yuan, a doubling that places it fourth in the sector. On paper, this looks like a clear case of "1+1+1>3."

What is surprising, however, is the substantial opposition expressed during the shareholder vote. Notably, nearly half of Xinda Securities' minority shareholders—those holding less than 5% of shares—cast their ballots against the deal. This raises a natural question: why would investors reject such a seemingly favorable arrangement?

The answer lies within the logic of arbitrage. In these transactions, a "cash option" is often offered to protect dissenting shareholders, allowing them to sell their shares back at a predetermined price. For Xinda Securities, that price was 17.75 yuan per share, while Dongxing Securities' option was set at 13.04 yuan per share. At the time of the shareholder meetings, Xinda's stock traded around 15 yuan and Dongxing's around 12 yuan, meaning the exercise price was significantly higher than the market value. By voting no, investors effectively secured a "guaranteed return coupon," locking in an opportunity to sell at a premium if prices fell, while retaining the option to hold if the stock rallied.

This dynamic means the negative votes were not a rejection of the merger's merits but a calculated move to secure a risk-free arbitrage gain, akin to winning the pot regardless of the outcome. The strategy reflects a rational decision for minority investors to obtain a put option, contrasting with institutional investors who may prioritize the long-term synergies of the combined entity.

For CICC, despite the high opposition ratios—10.71% overall and 46.83% among Xinda's minority holders—the outcome was never in doubt. With its controlling shareholder, Central Huijin Investment, holding a dominant stake, the votes could not overturn the proposal. The company simply needed to complete the legal procedural step, regardless of whether smaller investors approved for genuine reasons or strategic ones.

The substantial opposition is also drawing attention from regulators and the public, highlighting the need to refine rules and curb such arbitrage practices. This vote, therefore, represents more than just a tally; it is a precise exercise in interest calculation. The nearly half of minority shareholders who said no were not doubting CICC's future but rather mastering the game's rules to maximize their own guaranteed gains.

So, how did this arbitrage opportunity arise? It stems from the gap between the swap ratio and the cash option pricing. CICC offered a swap price of 16.05 yuan per share for Dongxing Securities and 19.11 yuan for Xinda, yet the cash option prices were set lower at 13.04 yuan and 17.75 yuan, respectively. While these exercise prices are above market value, they fall short of the swap's inherent value. This creates a trade-off: voting no and taking cash provides a modest premium over the market but sacrifices the greater upside of the share swap. It serves as a form of compensation, offering a sweetener to ease opposition and providing an exit for those who prefer liquidity, thereby softening resistance without derailing the merger's legitimacy.

Stepping back, this "three-in-one" merger is far more than a numbers game; it is a textbook example of internal resource consolidation within the "Huijin system." CICC has long styled itself as an "investment banking aristocrat," excelling in high-profile IPOs and cross-border deals. In contrast, Dongxing Securities, backed by China Orient Asset Management, and Xinda Securities, under China Cinda Asset Management, bring unique expertise in non-performing asset resolution and corporate distress relief. Combining these strengths fills a critical gap for CICC in "asset investment banking" and "industrial investment banking," positioning the new entity to assist not only with listings but also with bankruptcy restructuring, tapping into a trillion-yuan AMC market.

Another notable point is the speed of execution. From the first suspension announcement in November 2025 to approval in August 2026, the process took just 280 days—lightning-fast compared to other broker mergers that often span several years. This urgency reflects both policy support for building "first-class investment banks" and the strong push from Central Huijin as the controlling shareholder.

The story of CICC, Dongxing, and Xinda is not just a set of figures to be added or subtracted. On the surface, it is a securities firm merger, but at its core, it tests Central Huijin's resolve and capability in integrating its financial assets. While nearly half of the minority shareholders voted against it, they did so to exploit an institutionally provided arbitrage window. CICC, once the "aristocrat" of investment banking, now must navigate the transition from being a seller of tools to a builder of new structures. The 113.8 billion yuan merger has passed its initial hurdle, but the real challenge lies ahead: integrating three teams with vastly different cultures and overlapping businesses into a cohesive whole.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10